Leiden, the Netherlands, February 7, 2025: On December 15, 2024, Pharming Technologies B.V. (“Pharming”), a wholly-owned subsidiary of Pharming Group N.V., announced a recommended cash offer to the ...
Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full ...
Fintel on MSN
Pharming Group NV - Depositary receipt (PHAR) price target increased by 11.55% to 19.77
The average one-year price target for Pharming Group N.V. - Depositary Receipt (NasdaqGM:PHAR) has been revised to $19.77 / ...
Leiden, the Netherlands, February 20, 2025: On December 15, 2024, Pharming Technologies B.V. (“Pharming”), a wholly-owned subsidiary of Pharming Group N.V., announced a recommended cash offer to the ...
Pharming Group ( (PHAR) ) has issued an announcement.
When we look around, we are amazed at the speed with which the world is changing. Online fraud techniques such as Pharming and other cybercrime attacks are at an all-time high. To overcome such ...
Leiden, the Netherlands, October 6, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the implementation of an organizational restructuring to ...
Annual Report 2018 is available for download on the Pharming website today at http://www.pharming.com/investors/financial-documents Printed copies will be available ...
Leiden, The Netherlands, October 13, 2008. Biotech companyPharmingGroup NV ("Pharming" or "The Company") (Euronext: PHARM)announcedtoday the appointment of Dr Sijmen de Vries as ChiefExecutiveOfficer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback